Taking a bite out of the `hamburger disease.'

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Subject Terms:
    • Subject Terms:
    • Abstract:
      Discusses the drug treatment for E. coli infection being developed by the Calgary, Alberta-based firm Synsorb Biotech Inc. Test of the product, Synsorb-Pk, by a Japanese pharmaceutical company; Its successful prevention of progression to Hemolytic Uremic Syndrome; How it works; Company history and financial outlook.